Title : Molecular pharmacology of P2Y receptor subtypes.

Pub. Date : 2021 May

PMID : 33309519






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The antagonism of platelet P2Y12 receptors by cangrelor, ticagrelor or active metabolites of the thienopyridine compounds ticlopidine, clopidogrel and prasugrel reduces the ADP-induced platelet aggregation in patients with thrombotic complications of vascular diseases. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens